<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-214-6-22-31</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Социально-демографическая характеристика, особенности течения и лечения язвенного колита в Нижегородской области</article-title><trans-title-group xml:lang="en"><trans-title>Socio-demographic characteristics, features of the course and treatment of ulcerative colitis in the Nizhny Novgorod region</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8200-3293</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Злобин</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zlobin</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">zlomax@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5161-6436</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алексеева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alekseeva</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2329-071X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колодей</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolodey</surname><given-names>E. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1475-6584</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алексеева</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Alekseeva</surname><given-names>O. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение Нижегородской области «Нижегородская областная клиническая больница им. Н. А. Семашко»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nizhny Novgorod N. A. Semashko Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>07</month><year>2023</year></pub-date><volume>0</volume><issue>6</issue><fpage>22</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Злобин М.В., Алексеева А.А., Колодей Е.Н., Алексеева О.П., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Злобин М.В., Алексеева А.А., Колодей Е.Н., Алексеева О.П.</copyright-holder><copyright-holder xml:lang="en">Zlobin M.V., Alekseeva A.A., Kolodey E.N., Alekseeva O.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2303">https://www.nogr.org/jour/article/view/2303</self-uri><abstract><p>Целью исследования стало описание социально-демографической характеристики, особенностей течения и лечения пациентов с язвенным колитом. С марта 2019 г. по март 2021 г. осуществлялся сбор и систематизация информации о пациентах старше 18 лет в Нижегородской области, страдающих ВЗК. В регистр внесено и проанализировано 150 уникальных записей больных с язвенным колитом. По данным анализа число мужчин и женщин, страдающих язвенным колитом, сопоставимо - 47,3% и 52,7% соответственно. Медиана возраста всех пациентов - 43,0 года. Определение субъективной оценки времени появления первых симптомов установило, что медиана возраста приходится на 37,0 лет. Медиана продолжительности заболевания на момент включения в исследование составила 26,1 месяц. В течение первого года удается выявить патологию в 85,3% случаев: на сроке менее 3-х месяцев - 63,3%, в течение от 3-х до 6-ти месяцев - 16,0%, в период от 6-ти до 12-ти месяцев - 6,0%. Среди обследованных пациентов установлено преобладание тотального поражения толстой кишки - 54,6%; на втором месте - левосторонний вариант - 34,0%, реже всего встречался проктит - 11,3%. Согласно нашим данным, «усредненный пациент» - женщина либо мужчина среднего трудоспособного возраста, своевременно обращающийся за медицинской помощью, что позволяет установить диагноз в течение первых 3-х месяцев от появления симптомов; однако, несмотря на столь оптимистичное начало, в подавляющем числе случаев отмечается тотальное поражение толстой кишки и отсутствует адекватный контроль над заболеванием - сохраняется высокая активность заболевания (среднетяжелая атака) и рецидивирующее течение, что в свою очередь приводит к назначению повторных курсов кортикостероидов и лишь только в четверти случаев проводится смена терапии на генно-инженерные биологические препараты.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to describe the socio-demographic characteristics, features of the course and treatment of patients with ulcerative colitis. From March 2019 to March 2021, information was collected and systematized on patients over 18 years old in the Nizhny Novgorod region suffering from IBD. The registry included and analyzed 150 unique records of patients with ulcerative colitis. According to the analysis, the number of men and women with ulcerative colitis is comparable: men - 47.3% and 52.7%. The median age of all patients was 43.0 [19.0-83.0] years. Determination of a subjective assessment of the time of onset of the first symptoms found that the median age is 37.0 [14.7-83.2] years. The median duration of the disease at the time of inclusion in the study was 26.1 [3.4; 104.5] month. During the first year, it is possible to detect pathology in 85.3% of cases: for a period of less than 3 months in 63.3% of patients, within 3 to 6 months in 16.0%, in the period from 6- up to 12 months in 6.0%. Among the examined patients, the prevalence of total colitis was established - 54.6%; in second place - the leftside colitis - 34.0%, the least common was proctitis - 11.3%. According to our data, the “average patient” will be a woman or a man of average working age who seeks medical help in a timely manner, which allows a diagnosis to be made within the first 3 months from the onset of the first symptoms; however, despite such an optimistic start, in the vast majority of cases there is a total colitis and there is no adequate control over the disease - high activity of the disease (moderate attack) and a chronic recurrent course remain, which in turn leads to the appointment of repeated courses of corticosteroids and only in a quarter of cases, therapy is changed to genetically engineered biological agents.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>воспалительные заболевания кишечника</kwd><kwd>язвенный колит</kwd><kwd>региональные эпидемиологические особенности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>inflammatory bowel disease</kwd><kwd>ulcerative colitis</kwd><kwd>regional epidemiological features</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ng, S.C., Shi, H.Y., Hamidi N., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0.</mixed-citation><mixed-citation xml:lang="en">Ng, S.C., Shi, H.Y., Hamidi N., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Knyazev O. V., Belousova E. A., Abdulganieva D. I., et al. Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study. Almanac of Clinical Medicine. 2021;49(7):443-454. (in Russ.) doi: 10.18786/2072-0505-2021-49-061@@ Князев О. В., Белоусова Е. А., Абдулганиева Д. И. и др. Реальная практика лекарственной терапии среднетяжелых и тяжелых форм воспалительных заболеваний кишечника в России, Республике Беларусь и Республике Казахстан. Промежуточные результаты исследования INTENT. Альманах клинической медицины. 2021;49(7):443-454. doi: 10.18786/2072-0505-2021-49-061.</mixed-citation><mixed-citation xml:lang="en">Knyazev O. V., Belousova E. A., Abdulganieva D. I., et al. Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study. Almanac of Clinical Medicine. 2021;49(7):443-454. (in Russ.) doi: 10.18786/2072-0505-2021-49-061@@ Князев О. В., Белоусова Е. А., Абдулганиева Д. И. и др. Реальная практика лекарственной терапии среднетяжелых и тяжелых форм воспалительных заболеваний кишечника в России, Республике Беларусь и Республике Казахстан. Промежуточные результаты исследования INTENT. Альманах клинической медицины. 2021;49(7):443-454. doi: 10.18786/2072-0505-2021-49-061.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Available at: https://ueg.eu/p/61#whitebhttps://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/alcoholspecificdeathsintheuk/2021registrationsook. Access 27.01.2023.</mixed-citation><mixed-citation xml:lang="en">Available at: https://ueg.eu/p/61#whitebhttps://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/alcoholspecificdeathsintheuk/2021registrationsook. Access 27.01.2023.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Targownik, L.E., Kaplan, G.G., Witt, J., et al. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis. Am. J. Gastroenterol. 2020, 115, 128-137. doi: 10.14309/ajg.0000000000000503.</mixed-citation><mixed-citation xml:lang="en">Targownik, L.E., Kaplan, G.G., Witt, J., et al. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis. Am. J. Gastroenterol. 2020, 115, 128-137. doi: 10.14309/ajg.0000000000000503.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Burisch, J., Vardi, H., Schwartz, D., et al. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: A population-based study. Lancet Gastroenterol. Hepatol. 2020 May;5(5):454-464. doi: 10.1016/S2468-1253(20)30012-1.</mixed-citation><mixed-citation xml:lang="en">Burisch, J., Vardi, H., Schwartz, D., et al. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: A population-based study. Lancet Gastroenterol. Hepatol. 2020 May;5(5):454-464. doi: 10.1016/S2468-1253(20)30012-1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Last J. M. A Dictionary of Epidemiology. In: Last JM, Harris SS. (Hrsg.) New York: New York Oxford University Press; 2000.</mixed-citation><mixed-citation xml:lang="en">Last J. M. A Dictionary of Epidemiology. In: Last JM, Harris SS. (Hrsg.) New York: New York Oxford University Press; 2000.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Björnsson S., Tryggvason F., Jonasson J. G., et al. Incidence of inflammatory bowel disease in Iceland 1995-2009. A nationwide population-based study. Scand. J. Gastroenterol. 2015;50(11):1368-75. doi: 10.3109/00365521.2015.1047792.</mixed-citation><mixed-citation xml:lang="en">Björnsson S., Tryggvason F., Jonasson J. G., et al. Incidence of inflammatory bowel disease in Iceland 1995-2009. A nationwide population-based study. Scand. J. Gastroenterol. 2015;50(11):1368-75. doi: 10.3109/00365521.2015.1047792.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kurti Z., Vegh Z., Golovics P. A., et al. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Dig. Liver Dis. 2016 Nov;48(11):1302-1307. doi: 10.1016/j.dld.2016.07.012.</mixed-citation><mixed-citation xml:lang="en">Kurti Z., Vegh Z., Golovics P. A., et al. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Dig. Liver Dis. 2016 Nov;48(11):1302-1307. doi: 10.1016/j.dld.2016.07.012.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lophaven S. N., Lynge E., Burisch J. The incidence of inflammatory bowel disease in Denmark 1980-2013: A nationwide cohort study. Aliment. Pharmacol. Ther. 2017 Apr;45(7):961-972. doi: 10.1111/apt.13971.</mixed-citation><mixed-citation xml:lang="en">Lophaven S. N., Lynge E., Burisch J. The incidence of inflammatory bowel disease in Denmark 1980-2013: A nationwide cohort study. Aliment. Pharmacol. Ther. 2017 Apr;45(7):961-972. doi: 10.1111/apt.13971.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Greenland S. Validity and bias in epidemiological research. In Oxford Textbook of Public Health, 5th ed.; Detels, R., Beaglehole, R., Lansang, M.A., Gulliford, M., Eds.; Oxford University Press: Oxford, UK, 2009.</mixed-citation><mixed-citation xml:lang="en">Greenland S. Validity and bias in epidemiological research. In Oxford Textbook of Public Health, 5th ed.; Detels, R., Beaglehole, R., Lansang, M.A., Gulliford, M., Eds.; Oxford University Press: Oxford, UK, 2009.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chaparro M., Garre A., Núñez Ortiz A., et al.; The Epidem IBD Study Group Of Geteccu. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J Clin Med. 2021 Jun 29;10(13):2885. doi: 10.3390/jcm10132885.</mixed-citation><mixed-citation xml:lang="en">Chaparro M., Garre A., Núñez Ortiz A., et al.; The Epidem IBD Study Group Of Geteccu. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J Clin Med. 2021 Jun 29;10(13):2885. doi: 10.3390/jcm10132885.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Martins K. R., Araujo J. M., Cruz A. C., Luiz-Ferreira A. Epidemiologic aspects of inflammatory bowel disease in the Western region of Minas Gerais State. Arq Gastroenterol. 2021 Jul-Sep;58(3):377-383. doi: 10.1590/S0004-2803.202100000-63.</mixed-citation><mixed-citation xml:lang="en">Martins K. R., Araujo J. M., Cruz A. C., Luiz-Ferreira A. Epidemiologic aspects of inflammatory bowel disease in the Western region of Minas Gerais State. Arq Gastroenterol. 2021 Jul-Sep;58(3):377-383. doi: 10.1590/S0004-2803.202100000-63.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Osipenko M. F., Valuyskih E. Y., Svetlova I. O., Kulygina Y. A., Skalinskaya M. I., Bikbulatova E. A., Krasner Y. A. The value of the register with inflammatory bowel disease to assess the effectiveness of diagnostic and treatment activities. Eksp Klin Gastroenterol. 2016;(9):42-47. English, Russian. PMID: 29889394.@@ Осипенко М. Ф., Валуйских Е. Ю., Светлова И. О. и др. Значение регистра воспалительных заболеваний кишечника для оценки качества лечебно-диагностических мероприятий. Экспериментальная и клиническая гастроэнтерология 2016; 133 (9): 42-47.</mixed-citation><mixed-citation xml:lang="en">Osipenko M. F., Valuyskih E. Y., Svetlova I. O., Kulygina Y. A., Skalinskaya M. I., Bikbulatova E. A., Krasner Y. A. The value of the register with inflammatory bowel disease to assess the effectiveness of diagnostic and treatment activities. Eksp Klin Gastroenterol. 2016;(9):42-47. English, Russian. PMID: 29889394.@@ Осипенко М. Ф., Валуйских Е. Ю., Светлова И. О. и др. Значение регистра воспалительных заболеваний кишечника для оценки качества лечебно-диагностических мероприятий. Экспериментальная и клиническая гастроэнтерология 2016; 133 (9): 42-47.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bakulin I. G., Skalinskaya M. I., Skazyvaeva E. V. North-Western register of patients with inflammatory bowel diseases: achievements and lessons learned. Koloproktologia. 2022;21(1):37-49. (in Russ.) doi: 10.33878/2073-7556-2022-21-1-37-49.@@ Бакулин И. Г., Скалинская М. И., Сказываева Е. В. Северно-Западный регистр пациентов с воспалительными заболеваниями кишечника: достижения и уроки. Колопроктология. 2022; т. 21, № 1, с. 37-49.</mixed-citation><mixed-citation xml:lang="en">Bakulin I. G., Skalinskaya M. I., Skazyvaeva E. V. North-Western register of patients with inflammatory bowel diseases: achievements and lessons learned. Koloproktologia. 2022;21(1):37-49. (in Russ.) doi: 10.33878/2073-7556-2022-21-1-37-49.@@ Бакулин И. Г., Скалинская М. И., Сказываева Е. В. Северно-Западный регистр пациентов с воспалительными заболеваниями кишечника: достижения и уроки. Колопроктология. 2022; т. 21, № 1, с. 37-49.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Abdulganieva D.I., Bodryagina E. S., Odintsova A. Kh. The Clinico-epidemiological indices of intestine inflammatory diseases in the republic of Tatarstan. Lechaschi Vrach. 2013;(7):21-26. (in Russ.)@@ Абдулганиева Д. И., Бодрягина Е. С., Одинцова А. Х. Клинико-эпидемиологические показатели воспалительных заболеваний кишечника по Республике Татарстан. Лечащий врач. 2013; 7: 21-26.</mixed-citation><mixed-citation xml:lang="en">Abdulganieva D.I., Bodryagina E. S., Odintsova A. Kh. The Clinico-epidemiological indices of intestine inflammatory diseases in the republic of Tatarstan. Lechaschi Vrach. 2013;(7):21-26. (in Russ.)@@ Абдулганиева Д. И., Бодрягина Е. С., Одинцова А. Х. Клинико-эпидемиологические показатели воспалительных заболеваний кишечника по Республике Татарстан. Лечащий врач. 2013; 7: 21-26.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Osipenko M. F., Valuyskikh E. Yu., Svetlova I. O., Kulygina Yu.A., Skalinskaya M. I., Bikbulatova E. A., Krasner Ya. A. Register of inflammatory bowel diseases in Novosibirsk - 2016. The Siberian Scientific Medical Journal. 2017; 37(1): 61-67. (in Russ.)@@ Осипенко М. Ф., Валуйских Е. Ю., Светлова И. О. и соавт. Регистр воспалительных заболеваний кишечника в г. Новосибирске: итоги - 2016. Сибирский научный медицинский журнал. 2017; 37 (1): 61-67.</mixed-citation><mixed-citation xml:lang="en">Osipenko M. F., Valuyskikh E. Yu., Svetlova I. O., Kulygina Yu.A., Skalinskaya M. I., Bikbulatova E. A., Krasner Ya. A. Register of inflammatory bowel diseases in Novosibirsk - 2016. The Siberian Scientific Medical Journal. 2017; 37(1): 61-67. (in Russ.)@@ Осипенко М. Ф., Валуйских Е. Ю., Светлова И. О. и соавт. Регистр воспалительных заболеваний кишечника в г. Новосибирске: итоги - 2016. Сибирский научный медицинский журнал. 2017; 37 (1): 61-67.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bakulin I.G., Shkurko T. V., Parfenov A. I., Knyazev O. V., et al. On the issue of the prevalence and incidence of inflammatory bowel diseases in Moscow. Pharmateka. 2016; 2 (315): 69-73. (in Russ.)@@ Бакулин И. Г., Шкурко Т. В., Парфенов А. И., Князев О. В., и соавт. К вопросу о распространенности и заболеваемости воспалительными заболеваниями кишечника в Москве. Фарматека. 2016; 2 (315): 69-73.</mixed-citation><mixed-citation xml:lang="en">Bakulin I.G., Shkurko T. V., Parfenov A. I., Knyazev O. V., et al. On the issue of the prevalence and incidence of inflammatory bowel diseases in Moscow. Pharmateka. 2016; 2 (315): 69-73. (in Russ.)@@ Бакулин И. Г., Шкурко Т. В., Парфенов А. И., Князев О. В., и соавт. К вопросу о распространенности и заболеваемости воспалительными заболеваниями кишечника в Москве. Фарматека. 2016; 2 (315): 69-73.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ivashkin V.T., Shelygin Yu.A., Belousova E. A.: Abdulganieva D. I. et al. Clinical guidelines Ulcerative colitis. Ministry of Health of the Russian Federation. 2020. (in Russ.)@@ Ивашкин В. Т., Шелыгин Ю. А., Белоусова Е. А.: Абдулганиева Д. И. и соавт. Клинические рекомендации Язвенный колит. 2020; Министерство здравоохранения Российской Федерации.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Shelygin Yu.A., Belousova E. A.: Abdulganieva D. I. et al. Clinical guidelines Ulcerative colitis. Ministry of Health of the Russian Federation. 2020. (in Russ.)@@ Ивашкин В. Т., Шелыгин Ю. А., Белоусова Е. А.: Абдулганиева Д. И. и соавт. Клинические рекомендации Язвенный колит. 2020; Министерство здравоохранения Российской Федерации.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Belousova E. A., Abdulganieva D. I., Alexeeva O. P., et al. Social and demographic characteristics, features of disease course and treatment options of inflammatory bowel disease in Russia: results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445-463. (in Russ.) doi: 10.18786/2072-0505-2018-46-5-445-463.@@ Белоусова Е. А., Абдулганиева Д. И., Алексеева О. П. и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018;46(5):445-63. doi: 10.18786/2072-0505-2018-46-5-445-463.</mixed-citation><mixed-citation xml:lang="en">Belousova E. A., Abdulganieva D. I., Alexeeva O. P., et al. Social and demographic characteristics, features of disease course and treatment options of inflammatory bowel disease in Russia: results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445-463. (in Russ.) doi: 10.18786/2072-0505-2018-46-5-445-463.@@ Белоусова Е. А., Абдулганиева Д. И., Алексеева О. П. и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018;46(5):445-63. doi: 10.18786/2072-0505-2018-46-5-445-463.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Simian D., Fluxá D., Flores L., Lubascher J, et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016 June 14, vol. 22 (22), pp. 5267-5275. doi: 10.3748/wjg.v22.i22.5267</mixed-citation><mixed-citation xml:lang="en">Simian D., Fluxá D., Flores L., Lubascher J, et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016 June 14, vol. 22 (22), pp. 5267-5275. doi: 10.3748/wjg.v22.i22.5267</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yepes I., Carmona R., Díaz F., Marín-Jiménez I. Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia. Rev Col Gastroenterol. 2010;25(2):106-109.</mixed-citation><mixed-citation xml:lang="en">Yepes I., Carmona R., Díaz F., Marín-Jiménez I. Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia. Rev Col Gastroenterol. 2010;25(2):106-109.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Victoria C.R, Sassak L. Y., Nunes H. R. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol. 2009 Jan-Mar;46(1):20-5. doi: 10.1590/s0004-28032009000100009.</mixed-citation><mixed-citation xml:lang="en">Victoria C.R, Sassak L. Y., Nunes H. R. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol. 2009 Jan-Mar;46(1):20-5. doi: 10.1590/s0004-28032009000100009.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ng S. C., Zeng Z., Niewiadomski O., Tang W., et al. Early Course of Inflammatory Bowel Disease in a Population - Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology. 2016 Jan;150(1):86-95.e3; quiz e13-4. doi: 10.1053/j.gastro.2015.09.005.</mixed-citation><mixed-citation xml:lang="en">Ng S. C., Zeng Z., Niewiadomski O., Tang W., et al. Early Course of Inflammatory Bowel Disease in a Population - Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology. 2016 Jan;150(1):86-95.e3; quiz e13-4. doi: 10.1053/j.gastro.2015.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Malik T. A. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015 Dec;95(6):1105-22, v. doi: 10.1016/j.suc.2015.07.006.</mixed-citation><mixed-citation xml:lang="en">Malik T. A. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015 Dec;95(6):1105-22, v. doi: 10.1016/j.suc.2015.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kuenzig M. E., Lee S. M., Eksteen B., et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016 Dec 21;16(1):143. doi: 10.1186/s12876-016-0555-8.</mixed-citation><mixed-citation xml:lang="en">Kuenzig M. E., Lee S. M., Eksteen B., et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016 Dec 21;16(1):143. doi: 10.1186/s12876-016-0555-8.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Khalif I. L. Inflammatory bowel disease: current opportunities and unsolved problems in drug therapy. Consilium Medicum. 2015, no. 1, p. 33-34. (in Russ.)@@ Халиф И. Л. Воспалительные заболевания кишечника: современные возможности и нерешенные проблемы в лекарственной терапии. Consilium Medicum. 2015, № 1, с. 33-34.</mixed-citation><mixed-citation xml:lang="en">Khalif I. L. Inflammatory bowel disease: current opportunities and unsolved problems in drug therapy. Consilium Medicum. 2015, no. 1, p. 33-34. (in Russ.)@@ Халиф И. Л. Воспалительные заболевания кишечника: современные возможности и нерешенные проблемы в лекарственной терапии. Consilium Medicum. 2015, № 1, с. 33-34.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Zaharie R., Tantau A., Zaharie F., Tantau M., et al. Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. J Crohns Colitis. 2016 Mar, 10 (3), pp. 306-314. doi: 10.1093/ecco-jcc/jjv215.</mixed-citation><mixed-citation xml:lang="en">Zaharie R., Tantau A., Zaharie F., Tantau M., et al. Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. J Crohns Colitis. 2016 Mar, 10 (3), pp. 306-314. doi: 10.1093/ecco-jcc/jjv215.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Walldorf J., Twarz M., Schober C., et al. High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center. Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1502-1506. doi: 10.1097/MEG.0000000000001248.</mixed-citation><mixed-citation xml:lang="en">Walldorf J., Twarz M., Schober C., et al. High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center. Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1502-1506. doi: 10.1097/MEG.0000000000001248.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Karmiris K., Avgerinos A., Tavernaraki A., et al. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(4):429-436. doi: 10.1093/ecco-jcc/jjv232.</mixed-citation><mixed-citation xml:lang="en">Karmiris K., Avgerinos A., Tavernaraki A., et al. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(4):429-436. doi: 10.1093/ecco-jcc/jjv232.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Severs M., Spekhorst L. M., Mangen M. J.J., et al. Sex-related differences in patients with inflammatory bowel disease: results of 2 prospective cohort studies. Inflamm Bowel Dis. 2018; 24 (6): 1298-1306. doi: 10.1093/ibd/izy004.</mixed-citation><mixed-citation xml:lang="en">Severs M., Spekhorst L. M., Mangen M. J.J., et al. Sex-related differences in patients with inflammatory bowel disease: results of 2 prospective cohort studies. Inflamm Bowel Dis. 2018; 24 (6): 1298-1306. doi: 10.1093/ibd/izy004.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
